xylazine has been researched along with Anemia, Sickle Cell in 1 studies
Xylazine: An adrenergic alpha-2 agonist used as a sedative, analgesic and centrally acting muscle relaxant in VETERINARY MEDICINE.
xylazine : A methyl benzene that is 1,3-dimethylbenzene which is substituted by a 5,6-dihydro-4H-1,3-thiazin-2-ylnitrilo group at position 2. It is an alpha2 adrenergic receptor agonist and frequently used in veterinary medicine as an emetic and sedative with analgesic and muscle relaxant properties.
Anemia, Sickle Cell: A disease characterized by chronic hemolytic anemia, episodic painful crises, and pathologic involvement of many organs. It is the clinical expression of homozygosity for hemoglobin S.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Parshall, CJ | 1 |
| Vainisi, SJ | 1 |
| Goldberg, MF | 1 |
| Wolf, ED | 1 |
1 other study available for xylazine and Anemia, Sickle Cell
| Article | Year |
|---|---|
In vivo erythrocyte sickling in the Japanese sika deer (Cervus nippon): methodology.
Topics: Alkalosis; Anemia, Sickle Cell; Anesthesia, Inhalation; Animals; Bicarbonates; Carbon Dioxide; Deer; | 1975 |